Kairos Pharma
0 followers
KAPA
Performance
About Kairos Pharma
Kairos Pharma is a clinical-stage biopharmaceutical company focused on oncology, developing novel therapies to reverse cancer drug resistance and counter cancer-induced immune suppression. The company pursues immuno-oncology approaches, aiming to restore anti-tumor immune responses and enhance the efficacy of existing cancer drugs. Its pipeline includes antibody- and small molecule–based strategies such as ENV105 and other technologies designed to address resistance mechanisms across multiple cancer types, including prostate cancer, lung cancer, and glioblastoma.
Recent News
No recent news for this company.